Related references
Note: Only part of the references are listed.Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
Carla M. Startin et al.
FRONTIERS IN PSYCHIATRY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Andre Strydom et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease
Sid E. O'Bryant et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea et al.
LANCET NEUROLOGY (2018)
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Increased levels of plasma total tau in adult Down syndrome
Takashi Kasai et al.
PLOS ONE (2017)
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Eric D. Hamlett et al.
ALZHEIMERS & DEMENTIA (2017)
Clinical Assessment of Cognitive Decline in Adults with Down Syndrome
Marwan Sabbagh et al.
CURRENT ALZHEIMER RESEARCH (2016)
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
M. Florencia Iulita et al.
ALZHEIMERS & DEMENTIA (2016)
Congenital heart disease and Down syndrome: various aspects of a confirmed association
Sanaa Benhaourech et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2016)
Plasma antioxidant enzymes and lipoperoxidation status in children with Down syndrome
Jingyi He et al.
CLINICAL BIOCHEMISTRY (2016)
Plasma Amyloid Beta 1-42 and DNA Methylation Pattern Predict Accelerated Aging in Young Subjects with Down Syndrome
Rima Obeid et al.
NEUROMOLECULAR MEDICINE (2016)
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Neha Bhatnagar et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
Plasma N-Glycome Signature of Down Syndrome
Vincenzo Borelli et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Down Syndrome Preleukemia and Leukemia
Kelly W. Maloney et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues
Sid E. O'Bryant et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Current Estimate of Down Syndrome Population Prevalence in the United States
Angela P. Presson et al.
JOURNAL OF PEDIATRICS (2013)
Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
Antonia M. W. Coppus et al.
NEUROBIOLOGY OF AGING (2012)
Plasma Amyloid-beta as a Function of Age, Level of Intellectual Disability, and Presence of Dementia in Down Syndrome
Elizabeth Head et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Increased Soluble APP alpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients
Elisa Conti et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Plasma β-amyloid and duration of Alzheimer's disease in adults with Down syndrome
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Change in plasma Aβ peptides and onset of dementia in adults with Down syndrome
N. Schupf et al.
NEUROLOGY (2010)
The Relationship of Plasma Aβ Levels to Dementia in Aging Individuals With Down Syndrome
Yasuji Matsuoka et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Amyloid β concentrations in older people with Down syndrome and dementia
Emma L. Jones et al.
NEUROSCIENCE LETTERS (2009)
Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities
Sarah L. Ball et al.
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2008)
Elevated plasma β-amyloid peptide Aβ42 levels, incident dementia, and mortality in Down syndrome
Nicole Schupf et al.
ARCHIVES OF NEUROLOGY (2007)
Oxidative stress:: A bridge between Down's syndrome and Alzheimer's disease
Marianna Zana et al.
NEUROBIOLOGY OF AGING (2007)
Neuroanatomy of Down syndrome in vivo:: A model of preclinical Alzheimer's disease
Stefan J. Teipel et al.
BEHAVIOR GENETICS (2006)
Plasma amyloid β protein 1-42 levels in fetuses with Down syndrome
JL Bartha et al.
EARLY HUMAN DEVELOPMENT (2005)
Plasma amyloid β protein 1-42 levels are increased in old Down Syndrome but not in young Down Syndrome
PD Mehta et al.
NEUROSCIENCE LETTERS (2003)
CSF tau and Aβ42 levels in patients with Down's syndrome
T Tapiola et al.
NEUROLOGY (2001)
Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome
N Schupf et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
